Skip to content

Investigating the Effectiveness of Combined Treatment of Carboxytherapy with Platelet-Rich Plasma (PRP) Compared To PRP, in Patients with Vitiligo Treated with Phototherapy

Investigating the Effectiveness of Combined Treatment of Carboxytherapy with Platelet-Rich Plasma (PRP) Compared To PRP, in Patients with Vitiligo Treated with Phototherapy

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230601058354N1
Enrollment
30
Registered
2023-07-04
Start date
2023-07-20
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitiligo Disease. Vitiligo

Interventions

Intervention 1: Intervention group: In each Patient, two Similar Lesions are Selected for Treatment, which are Randomly Treated with PRP on the Right or Left Side. For all Patients, Light Therapy is P

Sponsors

Kerman University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: A Patient with Vitiligo

Exclusion criteria

Exclusion criteria: Photosensitive Diseases Segmental Vitiligo Patient with positive Kübner's History Previous History of Keloid Formation Pregnancy Breastfeeding History of Malignant Diseases Presence of Skin Infection at the Site Cardiovascular Disease Acute Embolism Thrombophlebitis Kidney Failure Use of Inhibitor Carbonic Anhydrase (Acetazolamide, Diclofenac), Systemic Disease Bleeding disorders or use of Anticoagulant Drugs Vasovagal Syncope

Design outcomes

Primary

MeasureTime frame
Status of Vitiligo Lesions. Timepoint: For all Patients, Light therapy was Performed Three times a week according to the Protocol. It Was Evaluated monthly during the Treatment and 4 Months after the end of the Treatment. Method of measurement: The Diagnosis of the Disease was Made Clinically by a Dermatologist and then confirmed with the help of Wood's Lamp Test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShima Estabragh

Kerman University of Medical Sciences

Shimaestabragh@gmail.com+98 34 3132 8000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026